bit.bio
Bit.bio specializes in the fields of coding and biology that determine the identity of every human cell.
bit.bio has raised €132M across 2 funding rounds from 8 investors, most recently a round in Jan 2026. Based in Cambridge, UK; active in Healthtech. Data as of 28 Oct 2026.
Total raised
€132M
€131,718,424
Funding rounds
2
Investors
8
distinct backers
Active since
2021-11
latest 2026-01
Funding by year
EUR raised per year · 2026 YTDbit.bio — funding by year — interactive chart.
Data table
| bit.bio — funding by year | |
|---|---|
| 2021 | €89M |
| 2026 | €43M |
Signals
High confidenceRaise-next likelihood30
base rate 30% for Other
- ▲ In typical raise window
- ▼ Down/flat last round
- ▼ Low backer re-investment
Exit likelihood21
base rate 11% (2+ rounds)
- ▲ €100M+ raised
- ▲ 5y since founding (typical exit age)
- ▲ Recent equity round, but funding momentum is down (may be rescue financing)
Timing: in window vs cohort gap · momentum down. Funding-only estimates, not predictions and not investment advice — see signals.
Funding rounds
2 rounds| Date | Stage | Amount | Investors | |
|---|---|---|---|---|
| 2026-01-12 | Other | €43M | M&G Investments | View deal → |
| 2021-11-08 | Series B | €89M | ARCH Venture Partners,Charles River Laboratories,Foresite Capital,Metaplanet,Puhua Capital,Resilience+1 more | View deal → |